Αρχική World News De-escalating immunotherapy in advanced or metastatic cancer – it is not time... World News De-escalating immunotherapy in advanced or metastatic cancer – it is not time yet Από Ogkologos - 26 Οκτωβρίου, 2026 7 0 Facebook Twitter Google+ Pinterest WhatsApp Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR ΚΑΡΚΙΝΟΣ ΟΥΡΟΔΟΧΟΥ ΚΥΣΤΕΩΣ 8 Μαρτίου, 2019 Sacituzumab Govitecan Earns Full Approval for Triple-Negative Breast Cancer 12 Μαΐου, 2021 EMA Recommends Extension of Indications for Datopotamab Deruxtecan 21 Αυγούστου, 2026 For Kids with Medulloblastoma, Trial Suggests Radiation Can Be Tailored 16 Ιουλίου, 2021 Φόρτωση περισσοτέρων HOT NEWS Dad Is Making Baby Giggle, But When He Makes A Sheep... Obesity May Help Tumors Survive and Grow, Mouse Study Suggests Pembrolizumab Improves Survival in Advanced Triple-Negative Breast Cancer Talk Cancer: How to have conversations that could save lives
